NCT00072722View on ClinicalTrials.gov

Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

April 30, 2005

Conditions
Prostate Cancer
Interventions
DRUG

CC-4047

Trial Locations (2)

77030

Baylor College of Medicine, Houston

80220-3706

University of Colorado Health Science Center, Denver

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY